US4605661A
(en)
*
|
1984-06-18 |
1986-08-12 |
Eli Lilly And Company |
Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
|
EP0225292A3
(de)
|
1985-12-06 |
1988-11-30 |
Ciba-Geigy Ag |
Einige N-substituierte Buttersäureamidderivate
|
DE3811574A1
(de)
*
|
1988-03-31 |
1989-10-19 |
Schering Ag |
N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
|
DE4138042C2
(de)
|
1991-11-19 |
1993-10-14 |
Biotechnolog Forschung Gmbh |
Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
|
US20030203976A1
(en)
*
|
1993-07-19 |
2003-10-30 |
William L. Hunter |
Anti-angiogenic compositions and methods of use
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
EP2226085B1
(de)
*
|
1993-07-19 |
2013-11-27 |
Angiotech Pharmaceuticals, Inc. |
Anti-Angiogene Mittel und Verfahren zu deren Verwendung
|
WO1997019086A1
(de)
|
1995-11-17 |
1997-05-29 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
Epothilonderivate, herstellung und verwendung
|
DE19607702A1
(de)
|
1996-02-29 |
1997-09-04 |
Biotechnolog Forschung Gmbh |
Heterozyklische Verbindungen, Herstellungsverfahren und Mittel
|
CZ297979B6
(cs)
|
1996-03-12 |
2007-05-16 |
Pg-Txl Company, L. P. |
Kompozice obsahující protinádorové lécivo konjugované s ve vode rozpustným polymerem, její pouzití pro výrobu léciva a implantovatelná lékarská pomucka
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
US20040106985A1
(en)
|
1996-04-26 |
2004-06-03 |
Jang G. David |
Intravascular stent
|
US5917084A
(en)
|
1996-07-03 |
1999-06-29 |
Millennium Pharmaceuticals, Inc. |
Antifungal agents
|
DE19645362A1
(de)
|
1996-10-28 |
1998-04-30 |
Ciba Geigy Ag |
Verfahren zur Herstellung von Epothilon A und B und Derivaten
|
US5969145A
(en)
*
|
1996-08-30 |
1999-10-19 |
Novartis Ag |
Process for the production of epothilones and intermediate products within the process
|
DE19636343C1
(de)
|
1996-08-30 |
1997-10-23 |
Schering Ag |
Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B
|
DE19645361A1
(de)
|
1996-08-30 |
1998-04-30 |
Ciba Geigy Ag |
Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II
|
DE19638870B4
(de)
|
1996-09-23 |
2009-05-14 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Tubulysine, Verfahren zu ihrer Gewinnung und sie enthaltende Mittel
|
ATE408612T1
(de)
*
|
1996-11-18 |
2008-10-15 |
Biotechnolog Forschung Gmbh |
Epothilone e und f
|
US6204388B1
(en)
|
1996-12-03 |
2001-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6867305B2
(en)
*
|
1996-12-03 |
2005-03-15 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
CA2273083C
(en)
|
1996-12-03 |
2012-09-18 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
|
US6660758B1
(en)
*
|
1996-12-13 |
2003-12-09 |
The Scripps Research Institute |
Epothilone analogs
|
US6380394B1
(en)
*
|
1996-12-13 |
2002-04-30 |
The Scripps Research Institute |
Epothilone analogs
|
DE19701758A1
(de)
|
1997-01-20 |
1998-07-23 |
Wessjohann Ludgar A Dr |
Epothilone-Synthesebausteine
|
WO1998038192A1
(de)
|
1997-02-25 |
1998-09-03 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
Seitenkettenmodifizierte epothilone
|
US20020086812A1
(en)
|
1997-03-04 |
2002-07-04 |
Schweinfest Clifford W. |
Methods and compositions for diagnosis and treatment of cancer
|
DE19713970B4
(de)
|
1997-04-04 |
2006-08-31 |
R&D-Biopharmaceuticals Gmbh |
Epothilone-Synthesebausteine II - Prenylderivate
|
CA2286610C
(en)
|
1997-04-18 |
2007-03-13 |
Studiengesellschaft Kohle Mbh |
Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
|
DE19849464A1
(de)
|
1997-04-30 |
2000-04-27 |
Schering Ag |
Wirkstofffreisetzende Stents, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
US6117659A
(en)
|
1997-04-30 |
2000-09-12 |
Kosan Biosciences, Inc. |
Recombinant narbonolide polyketide synthase
|
DE19821954A1
(de)
|
1997-05-15 |
1998-11-19 |
Biotechnolog Forschung Gmbh |
Verfahren zur Herstellung eines Epothilon-Derivats
|
DE19720312A1
(de)
|
1997-05-15 |
1998-11-19 |
Hoechst Ag |
Zubereitung mit erhöhter in vivo Verträglichkeit
|
US20030049841A1
(en)
*
|
1997-06-16 |
2003-03-13 |
Short Jay M. |
High throughput or capillary-based screening for a bioactivity or biomolecule
|
DE19726627A1
(de)
|
1997-06-17 |
1998-12-24 |
Schering Ag |
Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon
|
US6605599B1
(en)
*
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
DE59805727D1
(de)
|
1997-07-16 |
2002-10-31 |
Schering Ag |
Thiazolderivate, verfahren zur herstellung und verwendung
|
DE19735575A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue (C13-C15)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
DE19749717A1
(de)
|
1997-10-31 |
1999-05-06 |
Schering Ag |
Neue C1-C6-Bausteine zur Totalsynthese neuer Epothilon-Derivate sowie Verfahren zur Herstellung dieser Bausteine
|
DE19813821A1
(de)
|
1998-03-20 |
1999-09-23 |
Schering Ag |
Verfahren zur Herstellung von C1-C6-Bausteinen zur Totalsynthese von Epothilon und Epothilon-Derivaten
|
DE19735578A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue (C1-C6)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
DE19735574A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue [C1(Carboxa)-C6]-Fragmente, Verfahren zu ihrer Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
DE59814067D1
(de)
|
1997-08-09 |
2007-09-06 |
Bayer Schering Pharma Ag |
Neue epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
|
DE19751200A1
(de)
|
1997-11-13 |
1999-05-20 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19744135C1
(de)
|
1997-09-29 |
1999-03-25 |
Schering Ag |
Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
US6365749B1
(en)
*
|
1997-12-04 |
2002-04-02 |
Bristol-Myers Squibb Company |
Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
|
US6320045B1
(en)
|
1997-12-04 |
2001-11-20 |
Bristol-Myers Squibb Company |
Process for the reduction of oxiranyl epothilones to olefinic epothilones
|
US6096757A
(en)
|
1998-12-21 |
2000-08-01 |
Schering Corporation |
Method for treating proliferative diseases
|
US6090601A
(en)
|
1998-01-23 |
2000-07-18 |
Kosan Bioscience |
Sorangium polyketide synthase
|
US6280999B1
(en)
|
1998-01-23 |
2001-08-28 |
Kosan Bioscience |
Sorangium polyketide synthases and encoding DNA therefor
|
US6683100B2
(en)
*
|
1999-01-19 |
2004-01-27 |
Novartis Ag |
Organic compounds
|
PT1052974E
(pt)
|
1998-02-05 |
2009-08-07 |
Novartis Ag |
Formulação farmacêutica contendo epotilona
|
DE19804673A1
(de)
*
|
1998-02-06 |
1999-08-12 |
Studiengesellschaft Kohle Mbh |
Verfahren zur Darstellung makrocyclischer Produkte durch ringschliessende Diin-Metathese
|
US6194181B1
(en)
|
1998-02-19 |
2001-02-27 |
Novartis Ag |
Fermentative preparation process for and crystal forms of cytostatics
|
FR2775187B1
(fr)
*
|
1998-02-25 |
2003-02-21 |
Novartis Ag |
Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
|
US6302838B1
(en)
|
1998-02-25 |
2001-10-16 |
Novartis Ag |
Cancer treatment with epothilones
|
AU758526B2
(en)
|
1998-02-25 |
2003-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues therof
|
US6399638B1
(en)
*
|
1998-04-21 |
2002-06-04 |
Bristol-Myers Squibb Company |
12,13-modified epothilone derivatives
|
US6407103B2
(en)
|
1998-04-21 |
2002-06-18 |
Bristol-Myers Squibb Pharma Company |
Indeno [1,2-c] pyrazol-4-ones and their uses
|
US6498257B1
(en)
*
|
1998-04-21 |
2002-12-24 |
Bristol-Myers Squibb Company |
2,3-olefinic epothilone derivatives
|
JPH11322611A
(ja)
*
|
1998-05-14 |
1999-11-24 |
Sankyo Co Ltd |
抗ウイルス剤
|
GB9810659D0
(en)
|
1998-05-18 |
1998-07-15 |
Ciba Geigy Ag |
Organic compounds
|
US6121029A
(en)
|
1998-06-18 |
2000-09-19 |
Novartis Ag |
Genes for the biosynthesis of epothilones
|
DE19826988A1
(de)
|
1998-06-18 |
1999-12-23 |
Biotechnolog Forschung Gmbh |
Epothilon-Nebenkomponenten
|
DE19830060A1
(de)
|
1998-06-30 |
2000-02-10 |
Schering Ag |
Epothilon-Derivate, Verfahren zu deren Herstellung, Zwischenprodukte und ihre pharmazeutische Verwendung
|
DE19923001A1
(de)
|
1999-05-13 |
2000-11-16 |
Schering Ag |
Epothilon-Derivate, Verfahren zu deren Herstellung, Zwischenprodukte und ihre pharmazeutische Verwendung
|
JP2002525026A
(ja)
*
|
1998-07-02 |
2002-08-13 |
ザ ボード オブ リージェンツ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
ポリケチドを作製するための方法
|
US20030199535A1
(en)
|
1998-07-30 |
2003-10-23 |
Claudio Cavazza |
Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
|
WO2000020601A2
(en)
*
|
1998-10-02 |
2000-04-13 |
Kosan Biosciences, Inc. |
Polyketide synthase enzymes and recombinant dna constructs therefor
|
DE19846493A1
(de)
|
1998-10-09 |
2000-04-13 |
Biotechnolog Forschung Gmbh |
DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
|
DE19848306A1
(de)
|
1998-10-14 |
2000-04-20 |
Schering Ag |
Verfahren zur Herstellung von Epothilon B und Derivaten sowie Zwischenprodukte für dieses Verfahren
|
WO2000026349A2
(en)
|
1998-10-29 |
2000-05-11 |
Kosan Biosciences, Inc. |
Recombinant oleandolide polyketide synthase
|
US6303767B1
(en)
|
1998-11-05 |
2001-10-16 |
Kosan Biosciences, Inc. |
Nucleic acids encoding narbonolide polyketide synthase enzymes from streptomyces narbonensis
|
US6410301B1
(en)
|
1998-11-20 |
2002-06-25 |
Kosan Biosciences, Inc. |
Myxococcus host cells for the production of epothilones
|
KR20070087132A
(ko)
|
1998-11-20 |
2007-08-27 |
코산 바이오사이언시즈, 인코포레이티드 |
에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법및 물질
|
EP1140944B1
(de)
|
1998-12-22 |
2003-08-27 |
Novartis AG |
Epothilonderivate und ihre verwendung als antitumormittel
|
US6780620B1
(en)
|
1998-12-23 |
2004-08-24 |
Bristol-Myers Squibb Company |
Microbial transformation method for the preparation of an epothilone
|
US6419692B1
(en)
|
1999-02-03 |
2002-07-16 |
Scimed Life Systems, Inc. |
Surface protection method for stents and balloon catheters for drug delivery
|
US6596875B2
(en)
|
2000-02-07 |
2003-07-22 |
James David White |
Method for synthesizing epothilones and epothilone analogs
|
EP1152764A4
(de)
|
1999-02-18 |
2005-03-23 |
Oxigene Inc |
Zusammenstellungen und methoden zur verwendung in der zielung der vaskularen zerstörung
|
DE19908767A1
(de)
|
1999-02-18 |
2000-10-19 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
US6406722B1
(en)
|
1999-02-18 |
2002-06-18 |
Robert G. Gallaher |
Method of treating viral infections and lesions with taxane compounds
|
DE19908760A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19954230A1
(de)
|
1999-11-04 |
2001-11-15 |
Schering Ag |
16-Halogen-Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
CN1209360C
(zh)
|
1999-02-18 |
2005-07-06 |
舍林股份公司 |
16-卤-依泊昔酮衍生物、其制备方法及其医药用途
|
DE19908765A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
16-Halogen-Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19908763A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19907588A1
(de)
|
1999-02-22 |
2000-08-24 |
Biotechnolog Forschung Gmbh |
C-21 Modifizierte Epothilone
|
HUP0200076A3
(en)
|
1999-02-22 |
2003-01-28 |
Bristol Myers Squibb Co |
C-21 modified epothilones, process for their preparation, pharmaceutical compositions containing them
|
DE19930111A1
(de)
|
1999-07-01 |
2001-01-04 |
Biotechnolog Forschung Gmbh |
C-21 Modifizierte Epothilone
|
US20020058286A1
(en)
|
1999-02-24 |
2002-05-16 |
Danishefsky Samuel J. |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6291684B1
(en)
|
1999-03-29 |
2001-09-18 |
Bristol-Myers Squibb Company |
Process for the preparation of aziridinyl epothilones from oxiranyl epothilones
|
US6211412B1
(en)
|
1999-03-29 |
2001-04-03 |
The University Of Kansas |
Synthesis of epothilones
|
US6603015B2
(en)
|
1999-03-29 |
2003-08-05 |
University Of Kansas |
Synthesis of epothilones
|
ATE275177T1
(de)
|
1999-04-06 |
2004-09-15 |
Seiko Epson Corp |
Tintenzusammensetzung enthaltend einen kupferkomplex-farbstoff
|
US6664288B1
(en)
|
1999-04-14 |
2003-12-16 |
Dana Farber Cancer Institute, Inc. |
Method and composition for the treatment of cancer
|
US7125875B2
(en)
*
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
PL215901B1
(pl)
*
|
1999-04-15 |
2014-02-28 |
Bristol Myers Squibb Co |
Cykliczny inhibitor bialkowych kinaz tyrozynowych, jego zastosowanie oraz kompozycja farmaceutyczna zawierajaca taki zwiazek
|
DE19954228A1
(de)
|
1999-11-04 |
2001-09-13 |
Schering Ag |
6-Alkenyl-und 6-Alkinyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
DE10015836A1
(de)
|
2000-03-27 |
2001-10-11 |
Schering Ag |
6-Alkenyl- und 6-Alkinyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
JP4707240B2
(ja)
*
|
1999-05-05 |
2011-06-22 |
アベンティス・フアーマ・リミテッド |
細胞接着調節剤としての尿素
|
KR100621185B1
(ko)
|
1999-09-09 |
2006-09-06 |
삼성전자주식회사 |
디디씨 모니터의 동작 기록형 마이크로컴퓨터의 제어방법
|
US6569867B2
(en)
|
1999-10-01 |
2003-05-27 |
Kosan Biosciences, Inc. |
Polyketide derivatives
|
US20020147197A1
(en)
|
1999-10-08 |
2002-10-10 |
Newman Michael J. |
Methods and compositions for enhancing pharmaceutical treatments
|
US20030054977A1
(en)
*
|
1999-10-12 |
2003-03-20 |
Cell Therapeutics, Inc. |
Manufacture of polyglutamate-therapeutic agent conjugates
|
US20020045220A1
(en)
*
|
1999-10-13 |
2002-04-18 |
Chaitan Khosla |
Biosynthesis of polyketide synthase substrates
|
CN1086389C
(zh)
*
|
1999-11-12 |
2002-06-19 |
中国科学院上海有机化学研究所 |
异埃坡霉素及合成方法
|
US20030036177A1
(en)
*
|
2002-08-13 |
2003-02-20 |
Joachim Strohhacker |
Single colonies of myxobacteria cells
|
JP2004500388A
(ja)
|
2000-03-01 |
2004-01-08 |
スローン−ケッタリング インスティトュート フォア キャンサー リサーチ |
エポチロン、その中間体およびその類似体の合成
|
US6518421B1
(en)
*
|
2000-03-20 |
2003-02-11 |
Bristol-Myers Squibb Company |
Process for the preparation of epothilone analogs
|
US6593115B2
(en)
*
|
2000-03-24 |
2003-07-15 |
Bristol-Myers Squibb Co. |
Preparation of epothilone intermediates
|
TWI310684B
(en)
*
|
2000-03-27 |
2009-06-11 |
Bristol Myers Squibb Co |
Synergistic pharmaceutical kits for treating cancer
|
DE10020517A1
(de)
*
|
2000-04-19 |
2001-10-25 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE10020899A1
(de)
|
2000-04-20 |
2001-10-25 |
Schering Ag |
9-Oxa-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
US6998256B2
(en)
*
|
2000-04-28 |
2006-02-14 |
Kosan Biosciences, Inc. |
Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
|
US6489314B1
(en)
|
2001-04-03 |
2002-12-03 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
US6838265B2
(en)
*
|
2000-05-02 |
2005-01-04 |
Kosan Biosciences, Inc. |
Overproduction hosts for biosynthesis of polyketides
|
WO2001092255A2
(en)
*
|
2000-05-26 |
2001-12-06 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
AU7902501A
(en)
|
2000-07-25 |
2002-02-05 |
Kosan Biosciences Inc |
Fermentation process for epothilones
|
CA2417358A1
(en)
|
2000-08-09 |
2002-02-14 |
Kosan Biosciences, Inc. |
Bio-intermediates for use in the chemical synthesis of polyketides
|
UA75365C2
(en)
*
|
2000-08-16 |
2006-04-17 |
Bristol Myers Squibb Co |
Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
|
CA2418479C
(en)
*
|
2000-08-18 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Prodrugs of betulinic acid derivatives for the treatment of cancer
|
US7766956B2
(en)
|
2000-09-22 |
2010-08-03 |
Boston Scientific Scimed, Inc. |
Intravascular stent and assembly
|
US6989450B2
(en)
*
|
2000-10-13 |
2006-01-24 |
The University Of Mississippi |
Synthesis of epothilones and related analogs
|
DE10051136A1
(de)
|
2000-10-16 |
2002-04-18 |
Ludger A Wessjohann |
Epothilone-Synthesebausteine III und Verfahren zur Herstellung von Epothilon B, D und Epothilonderivaten
|
ATE349412T1
(de)
*
|
2000-10-16 |
2007-01-15 |
R & D Biopharmaceuticals |
Epothilon-synthesebausteine i: unsymmetrisch substituierte acyloine und acyloinderivate, verfahren zu deren herstellung sowie deren verwendung zur herstellung von epothilonen und epothilonderivaten
|
CA2428425A1
(en)
|
2000-11-07 |
2002-08-01 |
Dana-Farber Cancer Institute, Inc. |
Method of treating hematologic tumors and cancers
|
US7070797B2
(en)
*
|
2000-11-07 |
2006-07-04 |
Dana Farber Cancer Institute, Inc. |
Method of treating hematologic tumors and cancers
|
US20040038324A1
(en)
*
|
2000-11-22 |
2004-02-26 |
Atadja Peter Wisdom. |
Epothilone resistant cell lines
|
GB0029895D0
(en)
*
|
2000-12-07 |
2001-01-24 |
Novartis Ag |
Organic compounds
|
CN1489466A
(zh)
|
2001-01-25 |
2004-04-14 |
����˹�ж�-����˹˹������˾ |
包含埃博霉素类似物的非肠道制剂
|
EP1938821B1
(de)
|
2001-01-25 |
2016-03-30 |
Bristol-Myers Squibb Company |
Formulierung eines Epothilon-Analogs zur Krebsbehandlung
|
WO2002058699A1
(en)
|
2001-01-25 |
2002-08-01 |
Bristol-Myers Squibb Company |
Pharmaceutical forms of epothilones for oral administration
|
US20030004338A1
(en)
*
|
2001-02-01 |
2003-01-02 |
Li Wen Sen |
Process for the preparation of epothilone analogs
|
US6893859B2
(en)
*
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
BR0207487A
(pt)
*
|
2001-02-20 |
2004-08-10 |
Brystol Myers Squibb Company |
Método de tratamento de tumores em mamìferos e uso de compostos de epotilona
|
EP1368030A1
(de)
*
|
2001-02-20 |
2003-12-10 |
Bristol-Myers Squibb Company |
Epothilon-derivative zur behandlung von refraktären tumoren
|
JP4499359B2
(ja)
|
2001-02-27 |
2010-07-07 |
ノバルティス アーゲー |
シグナル変換阻害剤とエポチロン誘導体とを含有してなる組合せ剤
|
ATE335746T1
(de)
*
|
2001-02-27 |
2006-09-15 |
Biotechnolog Forschung Gmbh |
Verfahren zur herstellung von epothilonen
|
ATE554756T1
(de)
*
|
2001-03-14 |
2012-05-15 |
Bristol Myers Squibb Co |
Kombination aus epothilon-analog und chemotherapeutika zur behandlung von proliferativen erkrankungen
|
DK1372650T3
(da)
|
2001-03-19 |
2009-03-16 |
Novartis Ag |
Kombinationer indeholdende et antidiarrémiddel og en epothilon eller et epothilonderivat
|
US20020169125A1
(en)
|
2001-03-21 |
2002-11-14 |
Cell Therapeutics, Inc. |
Recombinant production of polyanionic polymers and uses thereof
|
EP1383492A4
(de)
|
2001-03-23 |
2008-12-24 |
Napro Biotherapeutics Inc |
Molekulare konjugate zur verwendung in der krebstherapie
|
US7081454B2
(en)
*
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
US6900214B2
(en)
|
2001-03-29 |
2005-05-31 |
Bristol-Myers Squibb Company |
Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
|
EP1610751A4
(de)
|
2001-04-26 |
2006-05-24 |
Univ Texas |
Therapeutisches mittel/ligand-konjugat-zusammensetzungen, ihre syntheseverfahren und ihre anwendung
|
US6906188B2
(en)
*
|
2001-04-30 |
2005-06-14 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method for synthesizing epothilones and epothilone analogs
|
US20030023082A1
(en)
*
|
2001-05-15 |
2003-01-30 |
Gary Ashley |
Epothilone derivatives and methods for making and using the same
|
MXPA03010909A
(es)
|
2001-06-01 |
2004-02-17 |
Bristol Myers Squibb Co |
Derivados de epotilona.
|
PT1407784E
(pt)
|
2001-06-25 |
2011-03-03 |
Ajinomoto Kk |
Agentes antitumorais
|
US6933385B2
(en)
|
2001-08-03 |
2005-08-23 |
Schering Ag |
Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use
|
DE10138347A1
(de)
|
2001-08-03 |
2003-02-27 |
Schering Ag |
Geschützte 3,5-Dihydroxy-2,2-dimethyl-valeronitrile für die Synthese von Epothilonen- und Derivaten und Verfahren zur Herstellung
|
US6872715B2
(en)
*
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
BR0212107A
(pt)
*
|
2001-08-23 |
2004-08-24 |
Novartis Ag |
Análogos da ciclopropil e da ciclobutil epotilona
|
HUP0402341A3
(en)
|
2001-08-31 |
2005-11-28 |
Bristol Myers Squibb Company P |
Compositions containing thiazol-2-ylamines for the treatment of cancer
|
US20030176368A1
(en)
|
2001-09-06 |
2003-09-18 |
Danishefsky Samuel J. |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
PL369108A1
(en)
|
2001-09-06 |
2005-04-18 |
Schering Corporation |
17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
|
WO2003029195A1
(fr)
|
2001-09-28 |
2003-04-10 |
Sumika Fine Chemicals Co., Ltd. |
Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production
|
TW200300350A
(en)
|
2001-11-14 |
2003-06-01 |
Bristol Myers Squibb Co |
C-5 modified indazolylpyrrolotriazines
|
AU2002360430A1
(en)
|
2001-11-26 |
2003-06-10 |
Kosan Biosciences, Inc. |
14-methyl-epothilones
|
WO2003047586A1
(en)
*
|
2001-12-03 |
2003-06-12 |
Schering Corporation |
Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
|
DE10164592A1
(de)
|
2001-12-21 |
2003-07-03 |
Schering Ag |
C1-C6-Epothilon-Fragmente und Verfahren für die Herstellung von C1-C6-Fragmenten von Epothilonen und deren Derivaten
|
US6884608B2
(en)
|
2001-12-26 |
2005-04-26 |
Bristol-Myers Squibb Company |
Compositions and methods for hydroxylating epothilones
|
TW200303202A
(en)
|
2002-02-15 |
2003-09-01 |
Bristol Myers Squibb Co |
Method of preparation of 21-amino epothilone derivatives
|
US7585491B2
(en)
|
2002-12-13 |
2009-09-08 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
AU2003212457A1
(en)
|
2002-03-01 |
2003-09-16 |
University Of Notre Dame |
Derivatives of epothilone b and d and synthesis thereof
|
EP1340498A1
(de)
|
2002-03-01 |
2003-09-03 |
Schering Aktiengesellschaft |
Verwendung von Epothilonen zur Behandlung von mit proliferativen Prozessen assoziierten Gehirnerkrankungen
|
AU2003216491A1
(en)
|
2002-03-07 |
2003-09-22 |
The Board Of Trustees Of The University Of Illinois |
Microtubule stabilizing compounds
|
US7211593B2
(en)
|
2002-03-12 |
2007-05-01 |
Bristol-Myers Squibb Co. |
C12-cyano epothilone derivatives
|
ATE452896T1
(de)
*
|
2002-03-12 |
2010-01-15 |
Bristol Myers Squibb Co |
C3-cyanoepothilonderivate
|
US6900208B2
(en)
*
|
2002-03-28 |
2005-05-31 |
Bristol Myers Squibb Company |
Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
|
TW200400191A
(en)
*
|
2002-05-15 |
2004-01-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives
|
EP1575556A2
(de)
*
|
2002-05-20 |
2005-09-21 |
Kosan Biosciences, Inc. |
Verfahren zur verabreichung von epothilon d
|
US7008936B2
(en)
*
|
2002-06-14 |
2006-03-07 |
Bristol-Myers Squibb Company |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
|
TW200401638A
(en)
*
|
2002-06-20 |
2004-02-01 |
Bristol Myers Squibb Co |
Heterocyclic inhibitors of kinases
|
DE10232094A1
(de)
|
2002-07-15 |
2004-02-05 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
5-Thiaepothilone und 15-disubstituierte Epothilone
|
TWI329112B
(en)
*
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
IL166039A0
(en)
|
2002-07-31 |
2006-01-15 |
Schering Ag |
New effector conjugates process for their production and their pharmaceutical use
|
CN100439374C
(zh)
*
|
2002-08-02 |
2008-12-03 |
诺瓦提斯公司 |
埃坡霉素衍生物
|
WO2004013145A1
(en)
*
|
2002-08-02 |
2004-02-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
WO2004016269A1
(en)
|
2002-08-17 |
2004-02-26 |
The Queens Universlty Of Belfast |
Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimer
|
WO2004018635A2
(en)
|
2002-08-21 |
2004-03-04 |
Kosan Biosciences, Inc. |
Myxococcus xanthus bacteriophage mx9 transformation and integration system
|
EP1391213A1
(de)
|
2002-08-21 |
2004-02-25 |
Boehringer Ingelheim International GmbH |
Zusammensetzungen und Verfahren zur Behandlung von Krebs mit einem Maytansinoid-CD44-Antikörper Immunokonjugat und chemotherapeutische Mittel
|
US20040126379A1
(en)
|
2002-08-21 |
2004-07-01 |
Boehringer Ingelheim International Gmbh |
Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents
|
US7649006B2
(en)
*
|
2002-08-23 |
2010-01-19 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
MXPA05002113A
(es)
|
2002-08-23 |
2005-06-03 |
Sloan Kettering Inst Cancer |
Sintesis de epotilonas, intermediarios para ellas, analogos y usos de los mismos.
|
EP1530456A2
(de)
|
2002-08-23 |
2005-05-18 |
Munich Biotech AG |
Nichtvesikuläre kationische lipid-zubereitung
|
US6921769B2
(en)
*
|
2002-08-23 |
2005-07-26 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
EP1534710B1
(de)
|
2002-09-04 |
2007-10-24 |
Schering Corporation |
Pyrazolopyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
NZ539162A
(en)
|
2002-09-04 |
2006-07-28 |
Schering Corp |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
US20040043089A1
(en)
|
2002-09-04 |
2004-03-04 |
Rabie A-Bakr M |
Buguzhi agent and composition and methods of preparing and administering the same
|
EP1545533A1
(de)
|
2002-09-04 |
2005-06-29 |
Schering Corporation |
Pyrazolopyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
WO2004026229A2
(en)
|
2002-09-04 |
2004-04-01 |
Schering Corporation |
Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors
|
GB0221312D0
(en)
|
2002-09-13 |
2002-10-23 |
Novartis Ag |
Organic compounds
|
JP2005538740A
(ja)
|
2002-09-16 |
2005-12-22 |
アグサート・インターナショナル・エルエルシー |
食品媒介病原体及び腐敗検出装置及び方法
|
MXPA05003058A
(es)
|
2002-09-19 |
2005-05-27 |
Schering Corp |
Nuevas imidazopiridinas como inhibidores de cinasa dependientes de ciclina.
|
TWI283243B
(en)
|
2002-09-19 |
2007-07-01 |
Schering Corp |
Novel pyrazolopyridines as cyclin dependent kinase inhibitors
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
EP2280014B1
(de)
|
2002-09-23 |
2013-10-23 |
Bristol-Myers Squibb Company |
Verfahren zur Herstellung, Isolierung und Aufreinigung von Epothilon B
|
CN1694706A
(zh)
*
|
2002-09-23 |
2005-11-09 |
先灵公司 |
用作依赖细胞周期蛋白的激酶抑制剂的新的咪唑并吡嗪
|
ES2293015T3
(es)
|
2002-09-23 |
2008-03-16 |
Schering Corporation |
Imidazopirazinas como inhibidores de cinasas dependientes de ciclinas.
|
US20040058899A1
(en)
*
|
2002-09-25 |
2004-03-25 |
Klimko Peter G. |
Use of epothilones and analogs in conjunction with ophthalmic surgery
|
EP1545529A4
(de)
|
2002-09-30 |
2010-03-03 |
Bristol Myers Squibb Co |
Neue tyrosinkinase-hemmer
|
TW200501960A
(en)
|
2002-10-02 |
2005-01-16 |
Bristol Myers Squibb Co |
Synergistic kits and compositions for treating cancer
|
KR20050051688A
(ko)
|
2002-10-09 |
2005-06-01 |
코산 바이오사이언시즈, 인코포레이티드 |
에포틸론(Еpo) D + 5-플루오로우라실(FU)/겜시타빈
|
WO2004032866A2
(en)
|
2002-10-09 |
2004-04-22 |
Kosan Biosciences, Inc. |
Therapeutic formulations
|
AU2003264822A1
(en)
|
2002-10-11 |
2004-05-04 |
Dana-Farber Cancer Institute Inc |
Epothilone derivatives for the treatment of multiple myeloma
|
CN1297269C
(zh)
|
2002-10-15 |
2007-01-31 |
路易斯安那州州立大学及农业机械学院管理委员会 |
埃坡霉素衍生物用于治疗甲状旁腺功能亢进的用途
|
EP1585504A4
(de)
|
2002-11-06 |
2009-07-15 |
Azaya Therapeutics Inc |
Proteinstabilisierte liposomale formulierungen pharmazeutischer wirkstoffe
|
JP4641941B2
(ja)
|
2002-11-07 |
2011-03-02 |
コーサン バイオサイエンシーズ, インコーポレイテッド |
トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法
|
BR0315537A
(pt)
|
2002-11-14 |
2005-09-27 |
Celmed Oncology Usa Inc |
Pró-drogas ativadas por peptìdeo desformilase
|
DK1567524T3
(da)
|
2002-11-28 |
2009-11-16 |
Wolfgang Richter |
Thia-epothilonderivater til behandling af cancer
|
AU2003291872A1
(en)
|
2002-12-04 |
2004-06-23 |
Inrs (Institut National De Recherche Scientifique) |
An exopolysaccharides delivery system for active molecules
|
AU2003294796A1
(en)
|
2002-12-05 |
2004-06-23 |
Schering Ag |
Epothilone analogs for site specific delivery in the treatment of proliferative diseases
|
DE10256982A1
(de)
|
2002-12-05 |
2004-06-24 |
Schering Ag |
Neue Effektor-Konjugate, Verfahren zu Ihrer Herstellung und Ihre Pharmazeutische Verwendung
|
CA2510610A1
(en)
|
2002-12-09 |
2004-06-24 |
Novartis Ag |
Microtubule stabilisers for treating stenosis in stents
|
NZ541142A
(en)
|
2002-12-09 |
2008-07-31 |
Abraxis Bioscience Inc |
Compositions and methods of delivery of pharmacological agents
|
EP1575454A4
(de)
|
2002-12-09 |
2006-11-29 |
Medtronic Vascular Inc |
Modularer stent mit polymerbrücken an modularen kontaktstellen
|
AU2003303058A1
(en)
|
2002-12-12 |
2004-07-09 |
Conforma Therapeutics Corporation |
Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
|
TW200420565A
(en)
|
2002-12-13 |
2004-10-16 |
Bristol Myers Squibb Co |
C-6 modified indazolylpyrrolotriazines
|
GB0230024D0
(en)
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
WO2004063151A2
(en)
|
2003-01-03 |
2004-07-29 |
Bristol-Myers Squibb Company |
Novel tyrosine kinase inhibitors
|
WO2004078978A1
(en)
|
2003-02-26 |
2004-09-16 |
Bristol-Myers Squibb Company |
Compositions and methods for hydroxylating epothilones
|
GB0305928D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
AU2004226350A1
(en)
|
2003-03-28 |
2004-10-14 |
Kosan Biosciences, Inc. |
Devices, methods, and compositions to prevent restenosis
|